Psychiatric Disorders
Genomind Professional PGx Express FULL Mental Health Report™ is intended to provide genetic information to healthcare professionals which may aid in the selection of appropriate medications for individuals with mental illness and other brain disorders. This 24 gene report is designed to be adjunctive to a complete patient assessment, including but not limited to proper diagnosis, clinical history, assessment of concomitant co-morbidities and medications, family history, and other factors. Additional information may be found by consulting the Prescribing Information of various FDA-approved medications, or other relevant resources such as the FDA’s Table of Pharmacogenomic Biomarkers in Drug Labeling.
Our Prescription Products
Full Mental Health Report (24 Genes)
Used to inform treatment decisions for a range of mental health conditions.
Core Anxiety & Depression Report (15 Genes)
Used to inform treatment decisions focused on depression and anxiety.
Genomind Professional PGX Express
Genomind Professional PGx Express is a test that looks at certain genes that may affect your body’s sensitivity or response to certain drugs and other treatments. Genomind Professional PGx Express is the leading test of its kind and looks at a group of key genes specific to mental health treatments. Your clinician can order this test for guidance that helps inform treatment decisions for you.
Test Information
Genomind® Professional PGx Express™ Full Mental Health Report (24 Genes)
Our state-of-the-art lab tests for a curated panel of 24 genes used to inform treatment for many psychiatric conditions. The information provided by this report is designed to help clinicians make more informed treatment decisions, and to help avoid the painful process of trial and error.*
The Genomind Professional PGx Express test includes :
- Our most comprehensive test – 24 genes
- Genetic implications for 130 mental health medications
- 3 Report Summary Views for your Clinician
- Patient Level Report Access on Patient Gateway
- Expert Consultation for Your Clinician
- Genomind® Professional PGx Rx MetaType™ Card
- Your Gene Results are Good for Life
Genes We Analyze
Each report looks at both Pharmacodynamic and Pharmacokinetic
Pharmacodynamic
This refers to the effect that a drug has on your body. For example, a drug might bind to a certain receptor in your brain, or you might make a certain protein that increases your risk of a drug induced rash. These are all pharmacodynamic parameters.
Pharmacokinetic
This refers to the effect that your body has on a drug. For example, your body can absorb and metabolize certain drugs at different speeds which can help personalize medication dosage. These speeds are different between people and are known as pharmacokinetic parameters.
Gene Variations Summary
The gene variations report provides the patient genotype for each of the gene variants on our panel. The color coded genotype reflects the patients inherited alleles, or variants, at a particular location within the tested gene. The report also provides specific therapeutic guidance related to certain medications, or non-drug options like exercise or TMS
Gene Drug Interaction Summary
Each patient report includes a gene-drug interaction summary. The gene-drug interaction summary provides information about how the patient’s genetic profile interacts with medications commonly used in psychiatry. This summary table lists medications in alphabetical order by generic name and drug class.
Diagnosis-Specific Summary
Diagnosis-specific Summary Pages will provide a visual plot of drugs and augmentation strategies for a particular condition. The medication position will shift left or right based on known gene-drug interactions.
- Alert/Caution : Drugs will shift to the left if a patient has genetic variations that may reduce efficacy, increase likelihood of side effects or alter drug metabolism/absorption.
- Standard Options : Drugs that are not shifted indicate that there are no significant gene-drug interactions for the patient.
- PGx Guided Options : Drugs will be shifted to the right if the patient has genetic variations that may increase likelihood of efficacy or tolerability.
